BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1406720)

  • 1. Characterization of the binding of Bolton-Hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes.
    Braunwalder AF; Musmanno D; Galakatos N; Garlick RH; Haston WO; Rediske JJ; Wennogle L; Seligmann B; Sills MA
    Mol Immunol; 1992 Nov; 29(11):1319-24. PubMed ID: 1406720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C5a receptor assay for high throughput screening.
    Harris SR; Garlick RK; Miller JJ; Harney HN; Monroe PJ
    J Recept Res; 1991; 11(1-4):115-28. PubMed ID: 1886076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the polymorphonuclear leukocyte C5a receptor.
    Rollins TE; Springer MS
    J Biol Chem; 1985 Jun; 260(12):7157-60. PubMed ID: 3997862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW; Miller T
    J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
    J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling the granulocyte C5a receptor with a unique photoreactive probe.
    Johnson RJ; Chenoweth DE
    J Biol Chem; 1985 Jun; 260(12):7161-4. PubMed ID: 3997863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a receptor for C5a anaphylatoxin on human eosinophils.
    Gerard NP; Hodges MK; Drazen JM; Weller PF; Gerard C
    J Biol Chem; 1989 Jan; 264(3):1760-6. PubMed ID: 2912983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D
    Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    Huey R; Hugli TE
    J Immunol; 1985 Sep; 135(3):2063-8. PubMed ID: 4020139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a biotinylated somatostatin analog as a receptor probe.
    Schonbrunn A; Lee AB; Brown PJ
    Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site directed mutagenesis of the complement C5a receptor--examination of a model for its interaction with the ligand C5a.
    Pease JE; Burton DR; Barker MD
    Mol Immunol; 1994 Jul; 31(10):733-7. PubMed ID: 8035835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.
    Tousignant C; Guillemette G; Drapeau G; Télémaque S; Dion S; Regoli D
    Brain Res; 1990 Aug; 524(2):263-70. PubMed ID: 1705465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP; Mussap CJ; Burcher E
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a.
    Vlattas I; Sytwu II; Dellureficio J; Stanton J; Braunwalder AF; Galakatos N; Kramer R; Seligmann B; Sills MA; Wasvary J
    J Med Chem; 1994 Aug; 37(17):2783-90. PubMed ID: 8064805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo.
    Soruri A; Kiafard Z; Dettmer C; Riggert J; Köhl J; Zwirner J
    J Immunol; 2003 Mar; 170(6):3306-14. PubMed ID: 12626590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tachykinin receptors in endothelial cells of porcine artery.
    Saito R; Konishi H; Takano Y; Nonaka S; Sakaguchi K; Shimohigashi Y; Kamiya H
    Neurosci Lett; 1990 Mar; 110(3):337-42. PubMed ID: 1691473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.
    DeMartino JA; Van Riper G; Siciliano SJ; Molineaux CJ; Konteatis ZD; Rosen H; Springer MS
    J Biol Chem; 1994 May; 269(20):14446-50. PubMed ID: 8182049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE; Simpson SJ; Johnson R
    J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.